Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Tonsillitis I: Introduction

Tonsillitis I: Introduction

Tonsillitis is inflammation of the tonsils, which are two lymphoid tissue masses at the back of the throat. This condition can cause discomfort and irritation in the throat.
Etiology
Three primary contributing factors have been identified.

Pneumonia III: Complications and Assessment

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:

Bacterial Meningitis I: Introduction

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:

Microbiota of the Respiratory Tract

Microbiota of the Respiratory Tract

The human respiratory tract, comprising the upper and lower segments, serves as a critical interface with the external environment. The upper respiratory tract (URT)—including the nostrils, sinuses, pharynx, and oropharynx—is heavily colonized by microbes, while the lower respiratory tract (LRT), composed of the larynx, trachea, bronchi, and lungs, was long thought to be sterile. However, recent molecular studies have revealed that the lungs are not devoid of microbes but act more like...

Tonsillitis II: Management

Tonsillitis II: Management

This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Clinical characteristics, outcomes, and subtype diversity in hospitalized human rhinovirus (HRV) patients.

PloS one·2025

Same author

Orbital complications of pediatric acute rhinosinusitis in the pneumococcal conjugate vaccine era.

Pediatrics and neonatology·2024

Same author

Epidemiological and clinical characteristics of hospitalized human metapneumovirus patients in Israel, 2015-2021: A retrospective cohort study.

Journal of medical virology·2024

Same author

A Systematic Review and Clinical Presentation of Central Nervous System Complications of Severe Acute Respiratory Syndrome Coronavirus 2 in Hospitalized Pediatric Patients During the Coronavirus Disease 2019 Pandemic in Israel.

Pediatric neurology·2024

Same author

Early Outcome of Multisystem Inflammatory Syndrome in Neonates Diagnosed following Prenatal Maternal COVID-19 Infection: A Three-Case Series.

Pediatric reports·2023

Same author

Vaccine Hesitancy Phenomenon Evolution during Pregnancy over High-Risk Epidemiological Periods-"Repetitio Est Mater Studiorum".

Vaccines·2023

Search research articles

Related Experiment Video

Updated: Jun 27, 2026

Robot-Assisted Transcanal Endoscopic Ear Surgery for Congenital Cholesteatoma

Robot-Assisted Transcanal Endoscopic Ear Surgery for Congenital Cholesteatoma

Published on: December 15, 2023

Complicated otitis media and its implications.

Eugene Leibovitz¹

¹Pediatric Infectious Disease Unit, Soroka University Medical Center, Ben-Gurion University of the Negev, Beer-Sheva, Israel. eugenel@bgu.ac.il

|December 20, 2008

Summary

This summary is machine-generated.

Recurrent otitis media (OM) is often caused by new infections, not relapses, emphasizing the need for bacterial eradication. The pneumococcal conjugate vaccine (PCV7) may help prevent OM complications like mastoiditis.

More Related Videos

Endaural Endoscopic Atticoantrotomy (Retrograde Mastoidectomy) using a Constant Suction Bone-drilling Technique

Endaural Endoscopic Atticoantrotomy (Retrograde Mastoidectomy) using a Constant Suction Bone-drilling Technique

Published on: May 23, 2021

Related Experiment Videos

Last Updated: Jun 27, 2026

Robot-Assisted Transcanal Endoscopic Ear Surgery for Congenital Cholesteatoma

Robot-Assisted Transcanal Endoscopic Ear Surgery for Congenital Cholesteatoma

Published on: December 15, 2023

Endaural Endoscopic Atticoantrotomy (Retrograde Mastoidectomy) using a Constant Suction Bone-drilling Technique

Endaural Endoscopic Atticoantrotomy (Retrograde Mastoidectomy) using a Constant Suction Bone-drilling Technique

Published on: May 23, 2021

Area of Science:

Pediatric infectious diseases
Otolaryngology
Vaccinology

Background:

Complicated otitis media (OM), including persistent and recurrent acute otitis media (AOM), is a significant pediatric health issue.
Microbiological studies indicate that most recurrent AOM episodes within a month of antibiotic treatment are new infections, not relapses.

Purpose of the Study:

To highlight the importance of bacteriological eradication for preventing recurrent acute otitis media (R-AOM).
To present data on the impact of the seven-valent pneumococcal conjugate vaccine (PCV7) on AOM complications, specifically mastoiditis.

Main Methods:

Review of double-tympanocentesis studies comparing microbiology of initial and recurrent AOM episodes.
Analysis of data concerning the effects of PCV7 on AOM complications.

Main Results:

Most recurrent AOM episodes within one month post-antibiotic therapy are identified as new infections.
The seven-valent pneumococcal conjugate vaccine (PCV7) targets key AOM pathogens like Streptococcus pneumoniae.

Conclusions:

Bacteriological eradication is crucial for preventing subsequent R-AOM episodes.
PCV7 shows potential in reducing AOM complications, including mastoiditis.